Lungpacer Medical begins subject enrolment in AeroNova system trial
Lungpacer Medical has commenced subject enrolment in its Phase II STimulation to Activate RespIration (STARI) trial, assessing the feasibility, effectiveness…
Respiratory
-
-
Thermo Fisher launches new test to assess lung transplant rejection
Thermo Fisher Scientific has launched the new Molecular Microscope Diagnostic System for Lung (MMDx Lung), a new test to assist…
-
FDA grants 510(k) clearance to 4DMedical’s CT:VQ for respiratory diagnostics
The US Food and Drug Administration (FDA) has granted 510(k) clearance to 4DMedical’s non-contrast, computed tomography (CT)-based ventilation-perfusion imaging technology,…
-
FDA approves Thermo Fisher’s diagnostic test for new NSCLC treatment
The US Food and Drug Administration (FDA) has granted approval for Thermo Fisher Scientific's Oncomine Dx Target Test as a…
-
Respiree secures FDA 510(k) extension for cardio-respiratory wearable
The US Food and Drug Administration (FDA) has granted a second 510(k) clearance to expand the use of Respiree’s RS001…
-
FDA clears Neurent Medical’s NEUROMARK for chronic rhinitis treatment
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Neurent Medical's NEUROMARK system for the treatment of…
-
NeoGenomics introduces c-MET companion diagnostic for NSCLC
NeoGenomics has commercially launched the c-MET Companion Diagnostic (CDx) for use in non-small cell lung cancer (NSCLC), offering a 48-hour…
-
FDA grants breakthrough status to Roche’s VENTANA TROP2 device
The US Food and Drug Administration (FDA) has granted breakthrough device designation to Roche's computational pathology companion diagnostic (CDx) VENTANA…
-
Novocure’s device for metastatic NSCLC treatment gains CE Mark
Novocure has obtained CE Mark approval for its Optune Lua device to treat adults with metastatic non-small cell lung cancer…
-
AccuStem to launch MSC blood test for lung cancer screening in US
AccuStem Sciences is set to launch the microRNA Signature Classifier (MSC) blood test for the US lung cancer screening programmes.…
